Abstract: Hydrophobic interaction chromatography (HIC) is a classic purification tool applied in protein and antibody, laboratory and industrial production process. It has been mainly used for the removal of both product-related impurities such as aggregates, as well as process contaminants such as host cell proteins. This review will focus on the recent development of HIC in its applications in the industrial purification processes. The process economy and requirements of high product purity and quality have driven much of the recent advancement in HIC chromatography in terms of increased throughput and enhanced selectivity or resolution. Meanwhile, high throughput screening (HTS), design of experiments (DoE) and platform approach for process development have been applied to shorten the development time. The throughput improvement has been achieved through new resins with increased binding capacity, using dual salts for load conditioning, and operating in the flow-through mode. In addition, hydrophobic interaction membrane filter chromatography technology reduces bed volumes and buffer usage and potentially improves process throughput by reducing cycle time. Selectivity and/or resolution enhancements have been achieved through optimization of operation parameters such as temperature and efforts such as application of solvent additives.
INTRODUCTION
Recent advancements in biotech industry especially in the area of therapeutic monoclonal antibody production have led to increased emphasis on product quality, process capacity and production economy [1] . For recombinant proteins and monoclonal antibodies used as human therapeutics, the production process is required to address both host and process impurities as well as product-related impurities such as product aggregates. Significant advancements achieved recently have led to highly productive upstream cell culture processes. The downstream purification processes have increasingly become bottlenecks in harnessing the overall production productivity gains achieved by the high titer cell culture process [2] , while at the same time addressing some of the by-products, e.g. challenging harvests and increased product-related impurities caused by the intense cell culture processes. Due to potentially large market demand and economic considerations, the desired purity and product quality need to be achieved by a downstream purification process in an efficient and cost-effective manners.
Protein and antibody aggregates are commonly encountered challenges during the downstream process development. Aggregates of therapeutic proteins and monoclonal antibodies (mAbs) are not desirable [3] . Consequently, the levels of aggregates in biological therapeutics are controlled by the production process and storage conditions. Multiple chromatography steps are generally required to achieve the desired purity level for therapeutic mAbs. Ion *Address correspondence to this author at the Global Process Engineering, Process Development, Amgen Inc., Thousand Oaks, CA 91320, USA; Tel: (805) 447-4897; E-mail: yuefengl@amgen.com exchange chromatography (IEX) [4] , hydroxyapatite chromatography (HA) [5] , mixed mode chromatography [6, 7] and hydrophobic interaction chromatography (HIC) [8, 9] have all been demonstrated to be effective in aggregate removal. HIC separates biomolecules based on their hydrophobicity in the native state, thus it provides an orthogonal approach to other chromatography steps in mAb purification processes. Size exclusion chromatography (SEC) has been mainly used as analytical method instead of a purification tool for mABs due to its limited throughput.
Both the mechanism of action and practical application of HIC have been extensively studied and reviewed [10] [11] [12] , which established HIC as a powerful purification tool for aggregate removal. However, traditional HIC has several drawbacks. HIC has been traditionally operated in the bindand-elute mode and has relatively low binding capacity and process throughput, making it a less desirable choice for mAb processes that increasingly require high throughput. The strong hydrophobicity of some ligands may also lead to protein denaturation during HIC and potentially result in lower step yield [11, 13, 14] . In addition, the high salt concentration that results in the HIC elution pool limits the placement of the HIC step in the downstream process, and may also have an impact on the subsequent unit operations such as ultrafiltration/diafiltration (UF/DF) . For example, the high salt concentration may limit the diafiltration protein concentration during UF/DF if a large amount of protein or mAb needs to be processed. Due to the large number of factors involved in HIC, HIC step development can be complicated, take time, and consume significant resources.
Significant advancements in HIC have been made recently, leading to gains in the productivity of HIC. Chiefly among these are new resins [8, 15] , membrane HIC [16] [17] [18] [19] [20] [21] [22] , and operating HIC in the flow-through mode [23, 24] . These advancements significantly increased the process throughput of HIC. HIC operated in the flow-through mode also requires lower salt concentration, ameliorating concerns related to process continuity. In addition, advancements have also been made to allow faster and more efficient step development. Modeling work and mechanistic studies have provided new insights and additional understandings of HIC [25] [26] [27] [28] [29] [30] [31] 32] . A platform approach in process development for mAbs utilizes the process experience and knowledge accumulated in the biotech industry [4] , and in the case of HIC, helps to lower the number of resins and operational parameters to be evaluated, and improves the efficiency in step development. Most importantly, statistic design of experiment (DoE) and high throughput screening (HTS) further allow faster evaluation of a large number of operation parameters in a systematic manner [6, 7, 33] .
This review summarizes recent developments in the application of HIC for mAb purification, in particular aggregate removal, in the biotech industry. Specifically, this review will focus on the recent advancements that led to faster HIC step development, enhanced selectivity and resolution, and improved process throughput, which all could affect separation effectiveness for aggregates. While HIC is a powerful tool for aggregate removal, it needs to meet the increasingly demanding requirements in development efficiency, process throughput and process economy in order to be competitive and used for industrial purification process.
IMPROVE HIC STEP DEVELOPMENT EFFICIENCY
A large number of factors are known to affect HIC performance and need to be evaluated during the step development for HIC. From the stationary phase point of view; resin matrix, hydrophobic ligand type and density, resin pore size, and resin particle size are among the factors that need to be evaluated. From the mobile phase aspect; antibody concentration, amount of loading, type and concentration of the salting-out salt, pH, and operation temperature are factors to be included for evaluation. In addition, detergents, alcohols, polyols, amino acids and chaotropic agents can be added to the wash and/or elution to improve resolution and/or recovery [10, 26, 34] . While experienced chromatographers may be able to cut through the factors with a limited set of experiments, developing the HIC step for optimal yield and purity can still be time consuming due to the large number of factors involved. Mechanism-based modeling, HTS, DoE and experienced-based platform approach have been several of the most important tools explored to achieve efficiency gains and time savings in the step development.
Mechanism-Based Modeling
Mechanism-based modeling has been explored to predict the retention time of the protein in HIC with the aim to aid in the rational design of the HIC step. Since HIC separates proteins based on hydrophobicity, protein hydrophobicity has been the central theme in several of the modeling exercises [25] . Average surface hydrophobicity as estimated by 3-D structure and primary sequence information was initially used to predict retention time on HIC [28] . It was then shown that patches of hydrophobicity on protein surface or distribution of surface hydrophobicty, also estimated based on primary and 3-D structure information, can better predict retention time for certain proteins [29] . More recently, Ladiwala et al. calculated retention time using protein 3-D structure, primary sequence information and a new set of hydrophobicity descriptors that were based on solvent accessible protein surface area [30] . In addition, thermodynamic properties of the proteins, such as protein solubility under varied conditions, appeared to correlate well with retention time in several cases [31] .
Most of the modeling exercises have been valuable in providing additional understanding of the mechanism of HIC. However, modeling of the separation of a protein of interest from a large number of known and unknown host cell protein contaminants with varied folding status and posttranslational modifications, while appealing, appears to be a daunting task. Much of the modeling calls for 3-D structure information of the molecule of interest, which could be hard to obtain if the protein of interest is a novel one. Even the identities of impurities may be difficult to determine, and obtaining structural information will be even more difficult. The challenge is simpler if the focus is separation of a largely purified known protein monomer from its aggregates, since even though aggregates are often heterogeneous (dimers, tetramers, etc), higher multiples are usually more hydrophobic and better separated from the monomer than lower multiples.
Monoclonal antibody molecules (mAbs) may provide additional simplifications. Computer modeling is capable of providing 3-D structures from amino acid sequence data even for new mAb molecules. Fc domains of the mAbs, which are conservative within their sub IgG classes, were more hydrophobic than the Fab domain and were believed to dominate binding with the HIC stationary phase [35] . HIC modeling could potentially play a practical role in predicting operation conditions and aiding in the step development for aggregate removal by HIC. McCue et al.. applied a binary competitive Langmuir adsorption isotherm in combination with a spreading model to predict the separation of mAb monomer/aggregate using HIC [32] . Experimental results showed that a fraction of the aggregates irreversibly bound to the stationary phase under the conditions tested. Including that information improved the predictability of the model.
In practice, one could combine the mechanism-based modeling with other approaches, such as platform approaches, to limit the numbers of operational parameters to be evaluated for HIC step development for mAbs.
High Throughput Screening (HTS)
Kramarczyk et al. evaluated the HTS approach to develop HIC step aggregate removal for mAbs [33] . Using 96 well plates, the team was able to evaluate hundreds of mobile phase conditions and protein concentrations to assess protein solubility. They were then able to evaluate 480 batch binding and elution conditions and 8 HIC resins during resin screening. The results from the screening were reproducible. The batch-binding experiments carried out using filter plate were useful in the selection of salt type, resin and loading conditions. Direct translation of aggregate-monomer resolution between batch binding and column was difficult due to the fact that the batch binding had only one theoretical plate. The aggregate resolution was modest in the batch-binding experiments comparing to the column-based results. However, the salt concentration for aggregate elution matched well between the batch-binding experiments and the columns. In general, the yield and purity results from the screening were predictable of the column runs carried out in the lab scale, after taking into the considerations of the higher numbers of the theoretical plates in the columns.
96-well filter plates pre-filled with resins (or not) are now commercially available and have been used to support highthroughput process development (HTPD) by allowing parallel screening of chromatographic operation parameters for binding, washing and elution [6, 7] . Good correlation between results obtained from plate-based and column-based experiments has also been reported [6, 7] . Combination of DoE and 96-well filter plate screening have shown to identify chromatography conditions for optimal aggregate removal and step yield using a mixed mode resin Capto TM Adhere [6, 7] .
Driven by demands in proteomics and system biology, a large number of protein purification and analysis tools have been developed for high throughput protein purification and analysis [36] . Lab robotic/automation systems for liquid handling may be used to speed up the high throughput screening [36] . Fast assay method for size exclusion chromatography such as membrane-based HIC-HPLC [19] and high-throughput analytical instruments [36] may also be helpful in cutting down analysis time. DoE may be used to further aid in the selection of experimental conditions as well as subsequent data analysis [6, 7, 37] .
Platform Approach for mAb Purification
Downstream platforms for mAb purification have been presented by a number of biotech companies [4] Many downstream mAb processes have a Protein A affinity chromatography followed by two polishing column steps. The 1 st polishing step is typically carried out in the bind-and-elute mode. In most cases, the 2 nd polishing step is often an anion exchange chromatography step in the column or membrane format and carried out in the flow-through mode [4] . HIC has been used as one of the polishing steps [8, 23] . Because of the structural similarity among antibodies and the extensive experience biotech companies have accumulated, it is possible to limit the number of HIC resins and the type of salts to be evaluated during the HIC step development. Narrowing down the raw material choices will also be beneficial for manufacturing in term of raw material supply chain management.
ENHANCING HIC SELECTIVITY
Many operational parameters have been evaluated to achieve optimal HIC selectivity [9] . Solvent parameters play critical roles in HIC, and factors such as salts used for binding, pH and temperature have also been shown to affect protein retention time and selectivity [9] [10] [11] [12] 26] . Additives such as alcohols, detergents and chaotropic agents were shown to moderate the hydrophobic interaction and therefore the selectivity and resolution of HIC [9, 11, 34] . For the stationary phase, ligand type and density as well as the bead size also have impacts on selectivity and resolution of HIC [10, 12, 26] . The impacts of temperature and solvent additives on HIC selectivity will be discussed below.
Temperature
Temperature is known to affect HIC binding capacity and increased temperature generally leads to higher binding capacity due to the entropy-driven characteristics of the hydrophobic interaction [38] . However, the response, i.e. change in retention time, of any given protein to temperature is highly individual, suggesting that temperature can be optimized to improve HIC resolution [9] . HIC was carried out for a recombinant Fc-fusion protein at temperatures between 5-30 °C (Fig. 1) . As shown in Fig. (1) , the difference between the retention time of the molecule of interest and that of the incorrectly folded product-related impurity increased as the temperature decreased. Similar experiments can conceivably be carried out to identify the optimal temperatures for aggregate removal by HIC. Controlling temperature at manufacturing stetting is feasible, though it would add cost and may not be always convenient due to the need of additional piece of equipment. Fig. (1) . Impact of temperature on HIC selectivity. Figure 1A shows a linear regression of the plot of the natural log of the retention time of each species versus temperature, which indicates that the lines have different slopes. Figure 1B shows that decreased operational temperature leads to increased resolution between the product and product-related impurity. The impact of temperature on aggregate removal was not examined. Unpublished data.
Solvent Additives
In theory, any agent that can modulate protein hydrophobicity, protein solvent interactions, protein-resin ligand inter- 
Product of interest
Product-related impurity action, and the surface tension of water can potentially affect the selectivity of HIC. Additives such as amino acids, sugars, polyols, alcohols, detergents and chaotropic agents have all been examined to improve HIC performance [9, 11, 34, 39] .
Chaotropic agents ("salting-in salts") weaken hydrophobic interactions. In one case study, a combination of sodium thiocyanate, urea and glycerol were added to the wash buffer, which led to the removal of the majority of impurities during the wash and improved the purity of the elution pool [39] .
The amino acid arginine has been used as an effective effluent for HIC and affinity chromatography [34] . An arginine solution was shown to facilitate elution of tightly bound proteins such as IL-6 and activin [34] . Whether arginine alters the resolution would depend on the way arginine interacts with the protein surfaces, which are involved in binding to the HIC resin, in monomeric and aggregated state.
The hydrophobic moieties of the alcohols and detergents compete with protein for the adsorption sites on the HIC resin. Detergent and polyethylene glycol (PEG) were also used as displacers for HIC [40] . The presence of 0-5% PEG decreased the retention time of hemoglobin in HIC but significantly increased the yield [24] . PEG also improved impurity removal [24] . Unfortunately, the impacts on aggregate removal was not discussed. In both of these applications, PEG was presumed to act as weak hydrophobic competitor.
IMPROVING HIC THROUGHPUT FOR MAB PURI-FICATION
Traditional HIC media typically exhibit dynamic IgG binding capacities ranging from about 15 to 40 g/L at 10% breakthrough [41] , with most monoclonals exhibiting capacities of 20-30 g/L typically at 5% break-through. While HIC capacity is adequate for most applications, its capacity could become one of the factors that potentially limit its application in mAb production. Recent advancements in several areas have significantly improved the capacity and productivity of HIC. These advancements include using dual salts for loading [42] , new resin technologies [6, 15, 8] , operating HIC in a flow-through mode [23] , and membrane filter-based HIC [16] [17] [18] [19] [20] [21] [22] 43] .
Dual Salt Load Conditioning
Using of dual salts during HIC, in this reported case phosphate and citrate, were able to increase dynamic binding capacity to up to 3 times, from 16-20 g/L to 38-44 g/L (1% break-through), over that of single salt [42] . Protein solubility was also increased with dual salts [42] . Product quality profiles as assessed by CIEF and CEX-HPLC were equivalent to lower loads. Host cell contaminant clearance was also maintained. The aggregate levels in the HIC pools were also the same as that of the single salt. Dynamic binding capacity appeared to be less sensitive to loading flow rate in the case of dual salt comparing that to the mono salt. The authors proposed that increased hydrophobic surface area may have contributed to the increased dynamic binding capacity by dual salts. It would be interesting to know whether static binding capacity has also been increased.
New Resins
Improved HIC resins such as Toyopearl® phenyl-600M have recently been reported to have dynamic binding capacity (~10% break-through) of about 40 g/L for mAbs and 58 g/L for lysozyme [41] . The higher dynamic binding capacity is believed to be achieved through resin pore size optimization [8] Mass recovery for mAbs was reported to be greater than 90%.
Monoliths are denoted as the fourth-generation chromatography material (see reference [15] for review). In addition to their applications as matrix for capillary chromatography and capillary electrochromatography [44] , monolithic columns also hold promise for future application in industrial purification process. Monolith beds have large channels sizes of 2-5 m and employ convective mass transfer instead of diffusive transport in traditional chromatography. Consequently, the resolution and dynamic binding capacity of monolith-based chromatography are not affected by flow rates and fast operation becomes possible for large molecules such as mAbs, plasmid DNA and viral particles, making it possible to reduce process time and increase process productivity. Because of higher porosity, monolithic columns also had lower pressure drop than packed-bed columns. However, due to the reduced absolute surface area, monolithic columns typically have relatively low binding capacity for most proteins [15] . In the case of mAbs, which have molecular mass close to 150 kDa, the theoretical maximal binding capacity is expected to be 32.4 mg/ml, though theoretical capacity for larger molecules such as DNA and viral particles are significantly higher [15] . Due to their modest binding capacity and faster flow rate, monolith-based AEX and HIC columns operated in flow-through mode (see below) may find potential advantages in process throughput in comparing to traditional chromatography. Monolithic columns have been made commercially available in chromatography modes including affinity, ion exchange and hydrophobic interaction [15] . Monoliths have been successfully scaled up to 8 liter, and significantly larger scale is possible by arranging monolith columns in series, in parallel, or in continuous countercurrent multicolumn (Simulated Moving Bed) arrays [15, 45] .
Membrane HIC
Membrane absorbers with anion exchange ligands have recently seen increased applications in protein and mAb purification processes in biotech industry [54] . Membrane absorbers have large pore sizes and the mass transfer during membrane chromatography is believed to be convective (as monoliths) and not limited by diffusion [46] . AEX membrane absorbers such as Q membrane filters have been used as a polishing step in the flow-through mode and removed host cell impurities such as DNA and host cell proteins and provided significant viral reductions [47, 48] . In comparison to resin-based conventional AEX chromatography, Q membrane filter was shown to have significantly higher linear flow rate [48] , shorter process time and higher productivity, and significantly reduced buffer volumes [46] . While membrane chromatography units are typically used as disposables, eliminating cost for cleaning and reuse validation, multiple reuse of AEX membrane filter has recently been reported, led to further reduction of raw material cost [49] .
Membrane hydrophobic interaction chromatography was initially reported by Yang et al.. in 1998 [16] . In a subsequent report from the same laboratory, cellulose membranes bonded with four commonly used hydrophobic ligands, octyl, butyl, phenyl and polyethylene glycol were evaluated for protein and enzyme purification [17] It was reported that significantly faster purification was achieved with membrane HIC. The majority of work in membrane hydrophobic chromatography was later reported by Ghosh R. and his colleagues [18] [19] [20] [21] [22] 43] . Both polyvinylidene fluoride (PVDF) membrane [19] [20] [21] [22] 43] and paper-PEG membranes [18] have been examined both as analytical tools and for preparative purification for mAbs. Experimental results from a work by Ghosh group clearly demonstrated that membrane HIC was able to resolve various forms of aggregates from mAb monomers in the bind-and-elute mode [19, 43] . As shown in other modes of membrane chromatography, membrane HIC also has limited capacity if used for mAb purification. Therefore, it is advantageous to carry out the membrane HIC in the flow-through mode so that the majority of the load, i.e. the product of interest will be flowing through, leaving the limited capacity for absorption of aggregates and other impurities. Since mAb aggregates showed higher hydrophobicity and were eluted later than the monomer species [43] , it is conceivable that membrane HIC can be designed to be carried out in the flow-through mode for aggregate removal. It is expected that membrane HIC, when carried out in the flow-through mode, will also be able to achieve increased throughput, reduced buffer usage, and decreased raw material costs. Table 1 uses a presumptive example to illustrate that membrane HIC is potentially able to achieve higher throughput and lower buffer usage than the column-based HIC with both carried out in the flow-through manner. Membrane filters tend to have significantly higher linear flow rate which allows for a much smaller size of a filter comparing to that of a column. For example, in order to achieve an operational flow rate of 60 L/min, a 10 L membrane volume filter would be adequate vs. a column with a column volume of approximately 400 L (160 cm diameter x 20 cm bed height) ( Table 1) . It is assumed here that, when carried out in the flow through mode, the 10 L membrane would provide an equivalent performance for aggregate removal as that of the 400 L column. Consequently, the buffer usage and process time are significantly lower with the membrane chromatography, as illustrated in Table 1 . HIC membrane units are now commercially available and have been tested for aggregate removal in the flow-through mode (see below) [50] .
Flow-Through Mode
Flow-through mode, also known as negative chromatography, has been commonly used for anion exchange chromatography for antibody production in the biotech industry to achieve high throughput [4, 47, 48] . HIC can also be carried out in a flow-through mode, in which the product of interest flows through the column while the impurities such as aggregates and host cell proteins potentially with higher affinity with the resin are retained by HIC.
McNay et al. presented a case study evaluating the application of flow-through HIC chromatography (or negative mode) for aggregate removal for a large, heavily glycosylated protein [23] . The effects of chromatographic operating parameters, including salt level, pH, and column loading as a function of aggregate resolution, have been examined. The potential benefit of using the flow-through mode to process throughput was also discussed.
Lu et al. used HIC, carried out in the flow through-mode, to remove lipids from hemoglobin [24] . However, the effectiveness on aggregate removal was not discussed.
Fraud et al. examined the application of HIC membrane chromatography, carried out in the flow-through mode, for aggregate removal [50] . Aggregate retention by HIC was increased as the salt concentration increased for the load material. However, the power of aggregate removal appeared to be modest (up to 63% recovery of aggregates in the strip peak by water). The impact on yield as the function of increased salt concentration was not discussed.
Operating HIC in the flow-through mode provides several potential advantages over bind-and-elute operations. First, the throughput of HIC can be significantly higher and is no longer limited by the intrinsic dynamic binding capacity of the column as the protein of interest is flowing through the column. Since HIC is typically used as polishing column step, the amount of impurities such as host cell protein and aggregates typically represent no more than a small percentage of the product. Second, the salt concentration used in the flow-through mode is reduced compared to the binding-elution mode. Impurities such as aggregates are able to bind to the HIC resin at reduced salt concentration due to their higher hydrophobicity [43] . Decreased salt concentration not only reduces raw material and waste disposable costs but, potentially improves step yields. Reduced salt concentration in the elution pool is also helpful for subsequent steps such as UF/DF. High salt concentration in the product pool may limit the protein concentration during the diafiltration step, as combination of high salt concentration and high antibody concentration may lead to antibody precipitation or binding to the membranes and cause membrane fouling. In addition, eliminating the linear gradient elution step often applied during HIC would reduce process time, reduce the volumes and the number of buffers needed, and reduce the equipment requirement, all of which would lead to higher process throughput and increased flexibility for facility fit.
CONCLUSIONS
HIC is an important tool for aggregate removal in industrial purification processes for therapeutic proteins and mAbs. Traditional HIC has several drawbacks including relatively lower capacity and process throughput, the need to use high concentration of salt for binding and potential impact of high salt concentration on protein stability or aggregation, and potentially longer and resource-consuming development.
Requirements from process economics and high product quality for biotech industrial purification have been driving to recent HIC advancements, which led to significantly increased HIC throughput, much lower salt concentration for loading, and faster and more efficient step development timeline. Specifically, operating HIC in the flow-through mode significantly increased the capacity and process throughput for HIC and lowered the salt concentration required for loading. High-throughput screening, potentially in combination with DoE, robotic systems for liquid handling and high-throughput analytical tools, have demonstrated their potentials in reducing development timeline and improving development efficiency. New technologies such as membrane HIC and monoliths are promising in further improving HIC process throughput while retaining the power of aggregate removal by HIC.
